Price $2.11 |
Market Cap
38.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
43.4
|
P/B
3.38
|
P/S
1.54
|
Dividend %
-
|
|
P/CF
6.5
|
P/FCF
-
|
Op. Cash Flow
800
|
FCF
0.0
|
|
Op. Margin
7.60%
|
Net Margin
6.90%
|
ROE
62.30%
|
ROI
699.80%
|
|
ROA
6.70%
|
EPS Growth
102.50%
|
Current Ratio
1.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Valeant Pharmaceuticals Intl I (VRX) | $24.27 | - | - | 7.68B | Strong Buy |
| Neurometrix Inc (NURO) | $1.33 | - | - | 10M | Strong Buy |
| China Health Industries Holdin (CHHE) | $0.86 | - | - | 55.7M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.22 | - | - | 12M | Strong Buy |
| NeoGenomics, Inc. (NEO) | $14.05 | - | - | 935.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
